Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||
| Revenue [abstract] | ||||||||||||||
| Revenue | — |
1,215,200,000
EUR
|
— | — | — | — | — | — |
1,047,200,000
EUR
|
— | — | — | — | — |
| Expenses by nature [abstract] | ||||||||||||||
| Raw materials and consumables used | — |
35,300,000
EUR
|
— | — | — | — | — | — |
31,600,000
EUR
|
— | — | — | — | — |
| Classes of employee benefits expense [abstract] | ||||||||||||||
| Employee benefits expense | — |
212,500,000
EUR
|
— | — | — | — | — | — |
181,100,000
EUR
|
— | — | — | — | — |
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss | — |
448,400,000
EUR
|
— | — | — | — | — | — |
390,900,000
EUR
|
— | — | — | — | — |
| Other expenses, by nature | — |
415,900,000
EUR
|
— | — | — | — | — | — |
359,800,000
EUR
|
— | — | — | — | — |
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||
| Share of profit (loss) of associates accounted for using equity method | — |
1,000,000
EUR
|
— | — | — | — | — | — |
-
EUR
|
— | — | — | — | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||
| Comprehensive income |
-
EUR
|
8,000,000
EUR
|
-
EUR
|
-
EUR
|
-
EUR
|
-
EUR
|
8,000,000
EUR
|
-
EUR
|
2,700,000
EUR
|
-
EUR
|
-
EUR
|
2,700,000
EUR
|
-
EUR
|
-
EUR
|